Substituted benzoazepines as toll-like receptor modulators
US9718796B2 · kind B2 · utility
0Cited by
4References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 12, 2012 |
| Grant date | Aug 1, 2017 |
| Priority date | — |
| Expiry date | May 4, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, fibrotic disease, cardiovascular disease, infectious disease, inflammatory disorder, graft rejection, or graft-versus-host disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.